TippingPoint Biosciences

San Francisco, California, United States · Biotechnology, Health Care, Medical

TippingPoint Biosciences is a San Francisco-based therapeutic company focused on innovative drug discovery targeting the aberrant DNA in cancer cells. Led by CEO Dr. Laura Hsieh, the company has developed a novel platform for identifying first-in-class drugs for diseases related to dysfunctional DNA packaging. Their screening platform aims to directly target defective chromatin in disease cells wh

See plans & pricing → Track TippingPoint Biosciences’s funding, hiring, and signals — with verified contacts — on Fundz.